The Latest Breaking News on Diabetes

Puberty blockers trial set to proceed in England after legal challenge thrown out

A clinical trial into the benefits and risks of puberty blockers in teenagers is set to proceed after a legal challenge over the trial was thrown…

The National (Scotland) · Jul 31

The US public is fed up with RFK Jr. To really ‘make America healthy again’, it should look to Europe

Americans are dying younger than Europeans, despite being the wealthiest people on the planet. Wellness fads won’t change that, says public health expert Devi Sridhar

The Guardian - UK · Jul 30

GLP-1 Medicare Coverage: How to Get It for $50 (And the Catch)

A new CMS program finally brings Wegovy and Zepbound within reach for seniors. But a hidden rule about your deductible could cost you thousands.

Kiplinger · Jul 29

Daily Oral Weight Loss Pill Outperformed Oral Semaglutide On Weight And Blood Sugar In Type 2 Diabetes

In a 1,698-person trial, orforglipron beat oral semaglutide on A1C and weight in type 2 diabetes. Here is what was measured and what was not.

Medical Daily · Jul 28

ICER Finds Weight-Loss Drugs Cost-Effective, But Analysts Warn the Projected Savings Depend on Patients Staying On Them

ICER finds GLP-1s cost-effective for obesity, but analysts warn projected savings assume patients stay on treatment. What it means for coverage.

Medical Daily · Jul 27

Patients Paid Less for GLP-1s While Total Spending Climbed, and Formularies Have Been Swinging Ever Since

A study found GLP-1 out-of-pocket costs fell as total spending rose. Here is what formulary swings mean for your coverage at renewal.

Medical Daily · Jul 27

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

International Business Times UK · Jul 27

Restricted eating hours may reduce cognitive decline in older age, researchers find

Preliminary study shows older people who avoided food four hours before bed did better in problem solving tests

The Guardian - UK · Jul 26

Millions of people are losing weight using GLP-1s. How do the drugs affect their love lives?

Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood

The Guardian - AU · Jul 25

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.

Medical Daily · Jul 25